NYSE:TMOLife Sciences
Is Thermo Fisher (TMO) Quietly Rewiring Its AI Strategy Through New Data and Proteomics Alliances?
In April 2026, Thermo Fisher Scientific announced multiple collaborations, including a data partnership with HealthVerity and a proteomics-focused alliance with Precision Health Research Singapore, alongside new cell therapy manufacturing and biologics cell line development platforms and a global distribution deal for therapeutic drug monitoring assays.
Together, these moves deepen Thermo Fisher’s role across clinical development, precision health and advanced biologics manufacturing by...

